Global Opioid-induced Constipation Market Research Report 2018
- QYR2812062
- 126 Pages
- November 2018
- Pharmaceuticals
This report studies the global Opioid-induced Constipation market status and forecast, categorizes the global Opioid-induced Constipation market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The major manufacturers covered in this report
AstraZeneca
Takeda Pharmaceutical
Valeant Pharmaceuticals International
Abbott
Bayer
Boehringer Ingelheim
C.B. Fleet
Cosmo Pharmaceuticals
Daewoong
Daiichi Sankyo
GlaxoSmithKline
Ironwood Pharmaceuticals
Johnson & Johnson
Merck
Mundipharma
Nektar Therapeutics
Pfizer
Progenics Pharmaceuticals
Shionogi
SLA Pharma
Sucampo
Synergy Pharmaceuticals
Theravance
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Solid
Liquid
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Drugstore
Hospital
Others
The study objectives of this report are:
To analyze and study the global Opioid-induced Constipation capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Opioid-induced Constipation manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Opioid-induced Constipation are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Opioid-induced Constipation Manufacturers
Opioid-induced Constipation Distributors/Traders/Wholesalers
Opioid-induced Constipation Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Opioid-induced Constipation market, by end-use.
Detailed analysis and profiles of additional market players.
Global Opioid-induced Constipation Market Research Report 2018
1 Opioid-induced Constipation Market Overview
1.1 Product Overview and Scope of Opioid-induced Constipation
1.2 Opioid-induced Constipation Segment by Type (Product Category)
1.2.1 Global Opioid-induced Constipation Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Opioid-induced Constipation Production Market Share by Type (Product Category) in 2017
1.2.3 Solid
1.2.3 Liquid
1.3 Global Opioid-induced Constipation Segment by Application
1.3.1 Opioid-induced Constipation Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Global Opioid-induced Constipation Market by Region (2013-2025)
1.4.1 Global Opioid-induced Constipation Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Opioid-induced Constipation (2013-2025)
1.5.1 Global Opioid-induced Constipation Revenue Status and Outlook (2013-2025)
1.5.2 Global Opioid-induced Constipation Capacity, Production Status and Outlook (2013-2025)
2 Global Opioid-induced Constipation Market Competition by Manufacturers
2.1 Global Opioid-induced Constipation Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Opioid-induced Constipation Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Opioid-induced Constipation Production and Share by Manufacturers (2013-2018)
2.2 Global Opioid-induced Constipation Revenue and Share by Manufacturers (2013-2018)
2.3 Global Opioid-induced Constipation Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Opioid-induced Constipation Manufacturing Base Distribution, Sales Area and Product Type
2.5 Opioid-induced Constipation Market Competitive Situation and Trends
2.5.1 Opioid-induced Constipation Market Concentration Rate
2.5.2 Opioid-induced Constipation Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Opioid-induced Constipation Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Opioid-induced Constipation Capacity and Market Share by Region (2013-2018)
3.2 Global Opioid-induced Constipation Production and Market Share by Region (2013-2018)
3.3 Global Opioid-induced Constipation Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Opioid-induced Constipation Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Opioid-induced Constipation Consumption by Region (2013-2018)
4.2 North America Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)
4.3 Europe Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)
4.4 China Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)
4.5 Japan Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)
4.7 India Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)
5 Global Opioid-induced Constipation Production, Revenue (Value), Price Trend by Type
5.1 Global Opioid-induced Constipation Production and Market Share by Type (2013-2018)
5.2 Global Opioid-induced Constipation Revenue and Market Share by Type (2013-2018)
5.3 Global Opioid-induced Constipation Price by Type (2013-2018)
5.4 Global Opioid-induced Constipation Production Growth by Type (2013-2018)
6 Global Opioid-induced Constipation Market Analysis by Application
6.1 Global Opioid-induced Constipation Consumption and Market Share by Application (2013-2018)
6.2 Global Opioid-induced Constipation Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Opioid-induced Constipation Manufacturers Profiles/Analysis
7.1 AstraZeneca
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Opioid-induced Constipation Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AstraZeneca Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Takeda Pharmaceutical
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Opioid-induced Constipation Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Takeda Pharmaceutical Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Valeant Pharmaceuticals International
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Opioid-induced Constipation Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Valeant Pharmaceuticals International Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Abbott
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Opioid-induced Constipation Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Abbott Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Bayer
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Opioid-induced Constipation Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Bayer Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Boehringer Ingelheim
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Opioid-induced Constipation Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Boehringer Ingelheim Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 C.B. Fleet
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Opioid-induced Constipation Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 C.B. Fleet Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Cosmo Pharmaceuticals
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Opioid-induced Constipation Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Cosmo Pharmaceuticals Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Daewoong
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Opioid-induced Constipation Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Daewoong Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 Daiichi Sankyo
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Opioid-induced Constipation Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Daiichi Sankyo Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 GlaxoSmithKline
7.12 Ironwood Pharmaceuticals
7.13 Johnson & Johnson
7.14 Merck
7.15 Mundipharma
7.16 Nektar Therapeutics
7.17 Pfizer
7.18 Progenics Pharmaceuticals
7.19 Shionogi
7.20 SLA Pharma
7.21 Sucampo
7.22 Synergy Pharmaceuticals
7.23 Theravance
8 Opioid-induced Constipation Manufacturing Cost Analysis
8.1 Opioid-induced Constipation Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Opioid-induced Constipation
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Opioid-induced Constipation Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Opioid-induced Constipation Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Opioid-induced Constipation Market Forecast (2018-2025)
12.1 Global Opioid-induced Constipation Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Opioid-induced Constipation Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Opioid-induced Constipation Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Opioid-induced Constipation Price and Trend Forecast (2018-2025)
12.2 Global Opioid-induced Constipation Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Opioid-induced Constipation Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Opioid-induced Constipation Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
Figure Picture of Opioid-induced Constipation
Figure Global Opioid-induced Constipation Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Opioid-induced Constipation Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Solid
Table Major Manufacturers of Solid
Figure Product Picture of Liquid
Table Major Manufacturers of Liquid
Figure Global Opioid-induced Constipation Consumption (K Units) by Applications (2013-2025)
Figure Drugstore Examples
Table Key Downstream Customer in Drugstore
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Opioid-induced Constipation Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Opioid-induced Constipation Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Opioid-induced Constipation Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Opioid-induced Constipation Major Players Product Capacity (K Units) (2013-2018)
Table Global Opioid-induced Constipation Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Opioid-induced Constipation Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Opioid-induced Constipation Capacity (K Units) of Key Manufacturers in 2017
Figure Global Opioid-induced Constipation Capacity (K Units) of Key Manufacturers in 2018
Figure Global Opioid-induced Constipation Major Players Product Production (K Units) (2013-2018)
Table Global Opioid-induced Constipation Production (K Units) of Key Manufacturers (2013-2018)
Table Global Opioid-induced Constipation Production Share by Manufacturers (2013-2018)
Figure 2017 Opioid-induced Constipation Production Share by Manufacturers
Figure 2017 Opioid-induced Constipation Production Share by Manufacturers
Figure Global Opioid-induced Constipation Major Players Product Revenue (Million USD) (2013-2018)
Table Global Opioid-induced Constipation Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Opioid-induced Constipation Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Opioid-induced Constipation Revenue Share by Manufacturers
Table 2018 Global Opioid-induced Constipation Revenue Share by Manufacturers
Table Global Market Opioid-induced Constipation Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Opioid-induced Constipation Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Opioid-induced Constipation Manufacturing Base Distribution and Sales Area
Table Manufacturers Opioid-induced Constipation Product Category
Figure Opioid-induced Constipation Market Share of Top 3 Manufacturers
Figure Opioid-induced Constipation Market Share of Top 5 Manufacturers
Table Global Opioid-induced Constipation Capacity (K Units) by Region (2013-2018)
Figure Global Opioid-induced Constipation Capacity Market Share by Region (2013-2018)
Figure Global Opioid-induced Constipation Capacity Market Share by Region (2013-2018)
Figure 2017 Global Opioid-induced Constipation Capacity Market Share by Region
Table Global Opioid-induced Constipation Production by Region (2013-2018)
Figure Global Opioid-induced Constipation Production (K Units) by Region (2013-2018)
Figure Global Opioid-induced Constipation Production Market Share by Region (2013-2018)
Figure 2017 Global Opioid-induced Constipation Production Market Share by Region
Table Global Opioid-induced Constipation Revenue (Million USD) by Region (2013-2018)
Table Global Opioid-induced Constipation Revenue Market Share by Region (2013-2018)
Figure Global Opioid-induced Constipation Revenue Market Share by Region (2013-2018)
Table 2017 Global Opioid-induced Constipation Revenue Market Share by Region
Figure Global Opioid-induced Constipation Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Southeast Asia Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table India Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Opioid-induced Constipation Consumption (K Units) Market by Region (2013-2018)
Table Global Opioid-induced Constipation Consumption Market Share by Region (2013-2018)
Figure Global Opioid-induced Constipation Consumption Market Share by Region (2013-2018)
Figure 2017 Global Opioid-induced Constipation Consumption (K Units) Market Share by Region
Table North America Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Opioid-induced Constipation Production (K Units) by Type (2013-2018)
Table Global Opioid-induced Constipation Production Share by Type (2013-2018)
Figure Production Market Share of Opioid-induced Constipation by Type (2013-2018)
Figure 2017 Production Market Share of Opioid-induced Constipation by Type
Table Global Opioid-induced Constipation Revenue (Million USD) by Type (2013-2018)
Table Global Opioid-induced Constipation Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Opioid-induced Constipation by Type (2013-2018)
Figure 2017 Revenue Market Share of Opioid-induced Constipation by Type
Table Global Opioid-induced Constipation Price (USD/Unit) by Type (2013-2018)
Figure Global Opioid-induced Constipation Production Growth by Type (2013-2018)
Table Global Opioid-induced Constipation Consumption (K Units) by Application (2013-2018)
Table Global Opioid-induced Constipation Consumption Market Share by Application (2013-2018)
Figure Global Opioid-induced Constipation Consumption Market Share by Applications (2013-2018)
Figure Global Opioid-induced Constipation Consumption Market Share by Application in 2017
Table Global Opioid-induced Constipation Consumption Growth Rate by Application (2013-2018)
Figure Global Opioid-induced Constipation Consumption Growth Rate by Application (2013-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Opioid-induced Constipation Production Growth Rate (2013-2018)
Figure AstraZeneca Opioid-induced Constipation Production Market Share (2013-2018)
Figure AstraZeneca Opioid-induced Constipation Revenue Market Share (2013-2018)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceutical Opioid-induced Constipation Production Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Opioid-induced Constipation Production Market Share (2013-2018)
Figure Takeda Pharmaceutical Opioid-induced Constipation Revenue Market Share (2013-2018)
Table Valeant Pharmaceuticals International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals International Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Valeant Pharmaceuticals International Opioid-induced Constipation Production Growth Rate (2013-2018)
Figure Valeant Pharmaceuticals International Opioid-induced Constipation Production Market Share (2013-2018)
Figure Valeant Pharmaceuticals International Opioid-induced Constipation Revenue Market Share (2013-2018)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Opioid-induced Constipation Production Growth Rate (2013-2018)
Figure Abbott Opioid-induced Constipation Production Market Share (2013-2018)
Figure Abbott Opioid-induced Constipation Revenue Market Share (2013-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Opioid-induced Constipation Production Growth Rate (2013-2018)
Figure Bayer Opioid-induced Constipation Production Market Share (2013-2018)
Figure Bayer Opioid-induced Constipation Revenue Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Opioid-induced Constipation Production Growth Rate (2013-2018)
Figure Boehringer Ingelheim Opioid-induced Constipation Production Market Share (2013-2018)
Figure Boehringer Ingelheim Opioid-induced Constipation Revenue Market Share (2013-2018)
Table C.B. Fleet Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table C.B. Fleet Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure C.B. Fleet Opioid-induced Constipation Production Growth Rate (2013-2018)
Figure C.B. Fleet Opioid-induced Constipation Production Market Share (2013-2018)
Figure C.B. Fleet Opioid-induced Constipation Revenue Market Share (2013-2018)
Table Cosmo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cosmo Pharmaceuticals Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cosmo Pharmaceuticals Opioid-induced Constipation Production Growth Rate (2013-2018)
Figure Cosmo Pharmaceuticals Opioid-induced Constipation Production Market Share (2013-2018)
Figure Cosmo Pharmaceuticals Opioid-induced Constipation Revenue Market Share (2013-2018)
Table Daewoong Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daewoong Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Daewoong Opioid-induced Constipation Production Growth Rate (2013-2018)
Figure Daewoong Opioid-induced Constipation Production Market Share (2013-2018)
Figure Daewoong Opioid-induced Constipation Revenue Market Share (2013-2018)
Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Opioid-induced Constipation Production Growth Rate (2013-2018)
Figure Daiichi Sankyo Opioid-induced Constipation Production Market Share (2013-2018)
Figure Daiichi Sankyo Opioid-induced Constipation Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid-induced Constipation
Figure Manufacturing Process Analysis of Opioid-induced Constipation
Figure Opioid-induced Constipation Industrial Chain Analysis
Table Raw Materials Sources of Opioid-induced Constipation Major Manufacturers in 2017
Table Major Buyers of Opioid-induced Constipation
Table Distributors/Traders List
Figure Global Opioid-induced Constipation Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Opioid-induced Constipation Price (Million USD) and Trend Forecast (2018-2025)
Table Global Opioid-induced Constipation Production (K Units) Forecast by Region (2018-2025)
Figure Global Opioid-induced Constipation Production Market Share Forecast by Region (2018-2025)
Table Global Opioid-induced Constipation Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Opioid-induced Constipation Consumption Market Share Forecast by Region (2018-2025)
Figure North America Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Asia-Pacific Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Central & South America Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Central & South America Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Central & South America Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Opioid-induced Constipation Production (K Units) Forecast by Type (2018-2025)
Figure Global Opioid-induced Constipation Production (K Units) Forecast by Type (2018-2025)
Table Global Opioid-induced Constipation Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Opioid-induced Constipation Revenue Market Share Forecast by Type (2018-2025)
Table Global Opioid-induced Constipation Price Forecast by Type (2018-2025)
Table Global Opioid-induced Constipation Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Opioid-induced Constipation Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
